Ivermectin: A Multifaceted Drug With a Potential Beyond Anti-parasitic Therapy

Baneet Kaur • Cyril Blavo • Mayur S. Parmar, DOI: 10.7759/cureus.56025  Abstract Ivermectin was first discovered in the 1970s by Japanese microbiologist Satoshi Omura and Irish parasitologist William C. Campbell. Ivermectin has become a versatile…[...]

Read More

Long COVID clinical evaluation, research and impact on society: a global expert consensus

Andrew G. Ewing, David Joffe, Svetlana Blitshteyn, et. al., Annals of Clinical Microbiology and Antimicrobials volume 24, Article number: 27 (2025)  Abstract Background Long COVID is a complex, heterogeneous syndrome affecting over four hundred million people globally. There…[...]

Read More

A Comparative Study on Genotoxic and Oxidative DNA Damage in Oral Epithelial Cells of COVID-19 Suspected Patients

Yogitha Poojari • Senthil Murugan • P K. Sankaran • et. al. DOI: 10.7759/cureus.82593  Abstract Introduction The SARS-CoV-2 virus causes COVID-19 by chiefly infecting the nasal and oral mucosal cavities, where its spike proteins bind to angiotensin-converting…[...]

Read More

The Impact of COVID-19 Infection on the Development of Stroke, Pulmonary Embolism, and Myocardial Infarction: A Retrospective Study

Oya Güven • Gökhan Karakurt • Abdulrahman Naser • et. al. DOI: 10.7759/cureus.77665  Abstract Introduction: This study compares the period during which thromboembolic disease develops after contact with the virus before, during, and after the pandemic. Methods:…[...]

Read More